Behind the rosiglitazone controversy.
Expert Rev Clin Pharmacol
; 3(6): 723-5, 2010 Nov.
Article
in En
| MEDLINE
| ID: mdl-22111775
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Expert Rev Clin Pharmacol
Year:
2010
Document type:
Article
Affiliation country:
Hong Kong
Country of publication:
United kingdom